In this study, molecular classification of endometrial ... 3 years after surgery. After multivariable analysis, however, 3-year recurrence was associated with tumor stage and grade, but not ...

The following is a summary of “Geographic and racial disparities in the quality of surgical care among patients with ...

which upon examination revealed to be caused by a large tumor in her uterus. Following a thorough assessment of her health, the surgeons proceeded with the operation. Post-surgery, the doctors ...

The uterine sarcoma market size is expected to see strong growth in the next few years. It will grow to $3.59 billion in 2029 at a compound annual growth rate (CAGR) of 6.38%.” - The Business ...

Neoadjuvant nivolumab has demonstrated efficacy in patients with mismatch repair-deficient, surgically resectable endometrial cancer.

It can be used alone or in combination with other treatments, like surgery and radiation, to improve the patient’s chance for survival. Drugs that are used to treat uterine cancer include ...

As with uterine sarcoma, endometrial carcinoma (EC) usually affects the upper part (or body) of the uterus. EC can be classified by the type of cell that they originate from, with endometrial ...

Uterine sarcomas make up just three out of 100 cancers of the womb, but the symptoms are similar to more common, and non-cancerous, fibroid growths. In addition, womb cancers are commonly ...